Alzamend Neuro, Inc. (ALZN) Corporate Subsidiaries
Alzamend Neuro, Inc. (ALZN) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ALZN
CIK: 1677077
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 04/30
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Haskell & White LLP
Auditor SinceSince 4/30/2024 12:00:00 AM
Lead Engagement PartnerPatrick Ross
Audit LocationIrvine, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| RW | 2026-10-09 | — | RW Filing | 0001214659-26-012720 | View SEC Doc Filr Page |
| 8-K | 2026-09-29 | 2026-09-29 | 8-K Filing | 0001214659-26-012132 | View SEC Doc Filr Page |
| 10-Q | 2026-09-10 | 2026-07-31 | 10-Q Filing | 0001214659-26-011572 | View SEC Doc Filr Page |
| 4 | 2026-08-31 | 2026-08-26 | PRIMARY DOCUMENT | 0001214659-26-011121 | View SEC Doc Filr Page |
| 4/A | 2026-08-31 | 2026-04-14 | PRIMARY DOCUMENT | 0001214659-26-011111 | View SEC Doc Filr Page |
| 4/A | 2026-08-31 | 2026-04-14 | PRIMARY DOCUMENT | 0001214659-26-011110 | View SEC Doc Filr Page |
| PRE 14A | 2026-08-28 | 2026-10-19 | PRE 14A Filing | 0001214659-26-011083 | View SEC Doc Filr Page |
| S-1 | 2026-08-21 | — | S-1 Filing | 0001214659-26-010726 | View SEC Doc Filr Page |
| 4/A | 2026-08-20 | 2026-07-31 | PRIMARY DOCUMENT | 0001214659-26-010677 | View SEC Doc Filr Page |
| 3/A | 2026-08-20 | 2026-07-29 | PRIMARY DOCUMENT | 0001214659-26-010676 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-07-31 | PRIMARY DOCUMENT | 0001214659-26-009596 | View SEC Doc Filr Page |
| 3 | 2026-08-04 | 2026-07-29 | PRIMARY DOCUMENT | 0001214659-26-009595 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-07-31 | PRIMARY DOCUMENT | 0001214659-26-009594 | View SEC Doc Filr Page |
| 5 | 2026-08-04 | 2026-04-30 | PRIMARY DOCUMENT | 0001214659-26-009591 | View SEC Doc Filr Page |
| 5 | 2026-08-04 | 2026-04-30 | PRIMARY DOCUMENT | 0001214659-26-009590 | View SEC Doc Filr Page |
| 5 | 2026-08-04 | 2026-04-30 | PRIMARY DOCUMENT | 0001214659-26-009589 | View SEC Doc Filr Page |
| 5 | 2026-08-04 | 2026-04-30 | PRIMARY DOCUMENT | 0001214659-26-009588 | View SEC Doc Filr Page |
| 5 | 2026-08-04 | 2026-04-30 | PRIMARY DOCUMENT | 0001214659-26-009587 | View SEC Doc Filr Page |
| 5 | 2026-08-04 | 2026-04-30 | PRIMARY DOCUMENT | 0001214659-26-009586 | View SEC Doc Filr Page |
| 5 | 2026-08-04 | 2026-04-30 | PRIMARY DOCUMENT | 0001214659-26-009585 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | 8-K Filing | 0001214659-26-009469 | View SEC Doc Filr Page |
| 10-K | 2026-07-22 | 2026-04-30 | 10-K Filing | 0001214659-26-008832 | View SEC Doc Filr Page |
| 8-K | 2026-07-21 | 2026-07-21 | 8-K Filing | 0001214659-26-008772 | View SEC Doc Filr Page |
| 8-K | 2026-04-17 | 2026-04-17 | 8-K Filing | 0001214659-26-004806 | View SEC Doc Filr Page |
| 4 | 2026-04-16 | 2026-04-14 | PRIMARY DOCUMENT | 0001214659-26-004742 | View SEC Doc Filr Page |